SJ

Sergey Jakimov

Managing partner and co-founder at LongeVC
On the record
Represented by:
Share profile 
Link:
Bio
Edit

Sergey Jakimov is a founding partner of LongeVC, a VC investing in biotech companies and founders. He is a serial entrepreneur, having co-founded 3 deep-tech ventures and raised more than $50M in venture funding. He has advised several other startups in the therapeutics space, and since 2018, he has led the medical tech startup Longenesis (now he is a member board of directors). He is also a board member and co-founder of the Longevity Science Foundation. Sergey is a visiting lecturer at several universities, and he co-authored a master’s program in technology law at the Riga Graduate School of Law. He holds a BSc in International Affairs and two MScs in Political Science and Government and Law and Finance. He was named a Forbes Latvia 30 Under 30 in technology and healthcare in 2020.

Employment
Sign up to view all
  • LongeVC
    Managing partner and co-founder
  • Longevity Tech: From Niche to Mainstream in Venture Capital
    Sergey highlights the need to integrate longevity tech into mainstream healthcare. He notes, "Platform-stage longevity companies often require $20–40 million," exceeding typical VC check sizes. The shift to later-stage investments may limit early funding but could enhance project quality. A balanced capital continuum is crucial to avoid funding gaps in this emerging sector.